T2 Biosystems to Commercialize Test for Early Lyme Disease
T2 Biosystems plans to commercialize, a diagnostic test for early Lyme disease, with a goal of releasing it in the U.S. as an LDT in 2023.
Category: Allergy & Autoimmune
Allergy & Autoimmune
Latest
Allergy & Autoimmune
Latest
Genetic Test Diagnoses Certain Immune System Disorders
A next-gen sequencing test is facilitating treatment options and earlier diagnosis in family members who inherited a genetic abnormality.
Allergy & Autoimmune
Latest
New Test May Diagnose Lyme Disease More Effectively
A new testing mechanism for Lyme disease can better identify the disease sooner, show when people are cured, and diagnose reinfection.
Saliva Test Developed for Diagnosing Celiac Disease
Researchers from Ikerbasque and the UPV/EHU have developed a non-invasive method to help diagnose celiac disease using saliva.
Read More
AI Provides Faster Diagnosis for Debilitating Blistering Disease
Scientists have trained an artificial intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita.
Read More
Bridging the Care Gap for Celiac Disease
Find out how serology can aid in the diagnosis of this autoimmune disease during the pandemic, instead of biopsy.
Read More
FDA Clears Nova Lite DAPI dsDNA Crithidia luciliae Kit for Nova View
Automation using Nova View and the Nova Lite DAPI dsDNA Crithidia luciliae Kit can significantly improve laboratory turnaround time and reduce technician hands-on time.
Read More
ATCC Awarded HIV Reagent Program Contract
ATCC joins the National Institute of Allergy and Infectious Diseases’ team working on preclinical services for HIV therapeutics.
Read More
Proteomic Data from Immunovia’s Immray Platform Helps Diagnose Autoimmune Diseases
These are the first proteomic data allowing a differential analysis of four different inflammatory rheumatic diseases.
Read More
Vectra Testing, Biomarkers Help Predict Risk for CV Events in RA Patients
Myriad Genetics shared new data further demonstrating that Vectra testing and three additional biomarkers can help predict the risk of cardiovascular events in patients with rheumatoid arthritis.
Read More
Bio-Me, Siolta to Collaborate on Pediatric Allergy and Asthma Test
Siolta will provide both samples and insights into key criteria for Bio-Me to develop a rapid, detailed, and comprehensive diagnostic test for infants at risk of developing allergy and asthma.
Read More
FDA Clears Blood Test for Novel Allergic Sensitization to Red Meat
Thermo Fisher Scientific’s FDA cleared ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites.
Read More
NIAID Strategic Plan Details Covid-19 Research Priorities
Research is needed to improve our understanding of the virus and how it causes covid-19, and to develop strategies to mitigate illness and death.
Read More
FDA Covid-19 Update: Serological Test Validation and Education Efforts
The question of when we can return to work and resume our normal activities is one of the most critical issues facing our nation.
Read More
BARDA Awards Contract for Rapid Coronavirus In-Home Self-Test
No instrumentation or trained personnel would be needed to administer the test or to read the results.
Read More
SARS-CoV-2 Coronavirus Stable for Hours on Surfaces
The virus was detectable for up to 3 hours in aerosols, up to 4 hours on copper, up to 24 hours on cardboard, and up to 3 days on plastic and stainless steel.
Read More
CLP Reader Survey: Clinical Lab Testing for Covid-19
CLP is conducting this survey in order to understand how clinical labs are responding to the challenges of covid-19 testing.
Read More
COVID-19: FDA Gives Flexibility to New York State Department of Health, Issues Emergency Use Authorization for Roche Diagnostic
FDA has exercised enforcement discretion to give the New York State Department of Health permission to authorize lab testing for COVID-19.
Read More